A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248
NCT04617509
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacokinetic
Interventions
DRUG:
Formulation A GS-248
DRUG:
Formulation B GS-248
Sponsor
Gesynta Pharma AB
Collaborators
[object Object]
[object Object]